Pharmacological modulation of functional connectivity: the correlation structure underlying the phMRI response to d-amphetamine modified by selective dopamine D3 receptor antagonist SB277011A

Magnetic Resonance Imaging

Volumn 25, Issue 6, 2007, Pages 811-820

  Schwarz, Adam J ^a   Gozzi, Alessandro ^a   Reese, Torsten ^a   Heidbreder, Christian A ^a   Bifone, Angelo ^a  

^a GSK   (Italy)

Author keywords

d Amphetamine; Pharmacological MRI; SB277011A

Indexed keywords

DEXAMPHETAMINE; DOPAMINE; DOPAMINE 3 RECEPTOR BLOCKING AGENT; N [4 [2 (6 CYANO 1,2,3,4 TETRAHYDRO 2 ISOQUINOLINYL)ETHYL]CYCLOHEXYL] 4 QUINOLINECARBOXAMIDE; NEUROTRANSMITTER;

ANIMAL EXPERIMENT; ARTICLE; BRAIN MAPPING; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG SELECTIVITY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; LIMBIC SYSTEM; MALE; NERVE PROJECTION; NEUROMODULATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; REWARD; UNIVARIATE ANALYSIS; VENTRAL TEGMENTUM;

ANIMALS; BRAIN MAPPING; DEXTROAMPHETAMINE; DOPAMINE; IMAGE PROCESSING, COMPUTER-ASSISTED; LIGANDS; MAGNETIC RESONANCE IMAGING; MALE; NITRILES; PROSENCEPHALON; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D3; TECHNOLOGY, PHARMACEUTICAL; TETRAHYDROISOQUINOLINES; TIME FACTORS; TISSUE DISTRIBUTION;

RATTUS;

EID: 34447545521     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mri.2007.02.017     Document Type: Article

References (51)

1. Jenkins B.G., Chen Y.-C.I., and Mandeville J.B. Pharmacological magnetic resonance imaging (phMRI). In: van Bruggen N., and Roberts T. (Eds). Biomedical imaging in experimental neuroscience (2003), CRC Press, New York 155-209
2. Leslie R.A., and James M.F. Pharmacological magnetic resonance imaging: a new application for functional MRI. Trends Pharmacol Sci 21 8 (2000) 314-318
3. Chen Y.C., Galpern W.R., Brownell A.L., Matthews R.T., Bogdanov M., Isacson O., et al. Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: correlation with PET, microdialysis, and behavioral data. Magn Reson Med 38 3 (1997) 389-398
4. Stein E.A., Pankiewicz J., Harsch H.H., Cho J.-K., Fuller S.A., Hoffmann R.G., et al. Nicotine-induced limbic cortical activation in the human brain: a functional MRI study. Am J Psychiatry 155 8 (1998) 1009-1015
5. Reese T., Bjelke B., Porszasz R., Baumann D., Bochelen D., Sauter A., et al. Regional brain activation by bicuculline visualized by functional magnetic resonance imaging. Time-resolved assessment of bicuculline-induced changes in local cerebral blood volume using an intravascular contrast agent. NMR Biomed 13 (2000) 43-49
6. Nguyen T.V., Brownell A.-L., Chen Y.-C.I., Livni E., Coyle J.T., Rosen B., et al. Detection of the effects of dopamine receptor supersensitivity using pharmacological MRI and correlations with PET. Synapse 36 (2000) 57-65
7. Schwarz A., Gozzi A., Reese T., Bertani S., Crestan V., Hagan J., et al. Selective dopamine D(3) receptor antagonist SB-277011-A potentiates phMRI response to acute amphetamine challenge in the rat brain. Synapse 54 1 (2004) 1-10
8. Kalisch R., Salome N., Platzer S., Wigger A., Czisch M., Sommer W., et al. High trait anxiety and hyporeactivity to stress of the dorsomedial prefrontal cortex: a combined phMRI and Fos study in rats. Neuroimage 23 1 (2004) 382-391
9. Jenkins B.G., Sanchez-Pernaute R., Brownell A.L., Chen Y.C., and Isacson O. Mapping dopamine function in primates using pharmacologic magnetic resonance imaging. J Neurosci 24 43 (2004) 9553-9560
10. Gozzi A., Schwarz A.J., Reese T., Crestan V., Bertani S., Turrini G., et al. Functional magnetic resonance mapping of intracerebroventricular infusion of a neuroactive peptide in the anaesthetised rat. J Neurosci Methods 142 1 (2005) 115-124
11. 3 receptor function using pharmacological magnetic resonance imaging. Psychopharmacology (Berl) 180 4 (2005) 705-715
12. Chen Y.I., Choi J.K., and Jenkins B.G. Mapping interactions between dopamine and adenosine A2a receptors using pharmacologic MRI. Synapse 55 2 (2005) 80-88
13. Jones N., O'Neill M.J., Tricklebank M., Libri V., and Williams S.C. Examining the neural targets of the AMPA receptor potentiator LY404187 in the rat brain using pharmacological magnetic resonance imaging. Psychopharmacology (Berl) 180 4 (2005) 743-751
14. Littlewood C.L., Jones N., O'Neill M.J., Mitchell S.N., Tricklebank M., and Williams S.C. Mapping the central effects of ketamine in the rat using pharmacological MRI. Psychopharmacology (Berl) 186 1 (2006) 64-81
15. Breiter H.C., Gollub R.L., Weisskoff R.M., Kennedy D.N., Makris N., Berke J.D., et al. Acute effects of cocaine on human brain activity and emotion. Neuron 19 3 (1997) 591-611
16. Shah Y.B., Prior M.J., Dixon A.L., Morris P.G., and Marsden C.A. Detection of cannabinoid agonist evoked increase in BOLD contrast in rats using functional magnetic resonance imaging. Neuropharmacology 46 3 (2004) 379-387
17. Vollm B.A., de Araujo I.E., Cowen P.J., Rolls E.T., Kringelbach M.L., Smith K.A., et al. Methamphetamine activates reward circuitry in drug naive human subjects. Neuropsychopharmacology 29 9 (2004) 1715-1722
18. Kufahl P.R., Li Z., Risinger R.C., Rainey C.J., Wu G., Bloom A.S., et al. Neural responses to acute cocaine administration in the human brain detected by fMRI. Neuroimage 28 4 (2005) 904-914
19. McKie S., Del Ben C., Elliott R., Williams S., del Vai N., Anderson I., et al. Neuronal effects of acute citalopram detected by pharmacoMRI. Psychopharmacology (Berl) 180 4 (2005) 680-686
20. Skoubis P.D., Hradil V., Chin C.L., Luo Y., Fox G.B., and McGaraughty S. Mapping brain activity following administration of a nicotinic acetylcholine receptor agonist, ABT-594, using functional magnetic resonance imaging in awake rats. Neuroscience 137 2 (2006) 583-591
21. Reith M.E., Li M.Y., and Yan Q.S. Extracellular dopamine, norepinephrine, and serotonin in the ventral tegmental area and nucleus accumbens of freely moving rats during intracerebral dialysis following systemic administration of cocaine and other uptake blockers. Psychopharmacology (Berl) 134 3 (1997) 309-317
22. Biswal B., Yetkin F.Z., Haughton V.M., and Hyde J.S. Functional connectivity in the motor cortex of resting human brain using echo-planar MRI. Magn Reson Med 34 4 (1995) 537-541
23. Beckmann C.F., DeLuca M., Devlin J.T., and Smith S.M. Investigations into resting-state connectivity using independent component analysis. Philos Trans R Soc Lond B Biol Sci 360 1457 (2005) 1001-1013
24. Achard S., Salvador R., Whitcher B., Suckling J., and Bullmore E. A resilient, low-frequency, small-world human brain functional network with highly connected association cortical hubs. J Neurosci 26 1 (2006) 63-72
25. Fox M.D., Snyder A.Z., Vincent J.L., Corbetta M., Van Essen D.C., and Raichle M.E. The human brain is intrinsically organized into dynamic, anticorrelated functional networks. Proc Natl Acad Sci U S A 102 27 (2005) 9673-9678
26. Schwarz A.J., Gozzi A., Reese T., and Bifone A. Correlation analysis across subjects reveals pathways of functional connectivity in pharmacological MRI. Proc FENS Forum 2006 (Vienna, 8-12 July) (2006)
27. Schwarz A.J., Gozzi A., Reese T., and Bifone A. In vivo mapping of functional connectivity in neurotransmitter systems using pharmacological MRI. Neuro Image 34 4 (2007) 1627-1636
28. Schwarz A.J., Gozzi A., Reese T., and Bifone A. Sub-networks underlying d-amphetamine response revealed by cluster analysis. Magn Reson Med 57 (2007) 704-713
29. Soncrant T.T., Horwitz B., Holloway H.W., and Rapoport S.I. The pattern of functional coupling of brain regions in the awake rat. Brain Res 369 1-2 (1986) 1-11
30. Horwitz B., Rumsey J.M., and Donohue B.C. Functional connectivity of the angular gyrus in normal reading and dyslexia. Proc Natl Acad Sci U S A 95 15 (1998) 8939-8944
31. Dixon A.L., Prior M., Morris P.M., Shah Y.B., Joseph M.H., and Young A.M.J. Dopamine antagonist modulation of amphetamine response as detected using pharmacological MRI. Neuropharmacology 48 2 (2005) 236-245
32. 3 receptors in drug addiction: a review of pharmacological evidence. Brain Res Brain Res Rev 49 1 (2005) 77-105
33. Gozzi A., Schwarz A.J., Reese T., Bertani S., Crestan V., and Bifone A. Region-specific effects of nicotine on brain activity: a pharmacological MRI study in the drug-naïve rat. Neuropsychopharmacology 31 8 (2006) 1690-1703
34. Zaharchuk G., Mandeville J.B., Bogdanov Jr. A.A., Weissleder R., Rosen B.R., and Marota J.J. Cerebrovascular dynamics of autoregulation and hypoperfusion. An MRI study of CBF and changes in total and microvascular cerebral blood volume during hemorrhagic hypotension. Stroke 30 10 (1999) 2197-2204
35. Mandeville J.B., Marota J.J.A., Kosofsky B.E., Keltner J.R., Weissleder R., Rosen B., et al. Dynamic functional imaging of relative cerebral blood volume during rat forepaw stimulation. Magn Reson Med 39 (1998) 615-624
36. Schwarz A.J., Reese T., Gozzi A., and Bifone A. Functional MRI using intravascular contrast agents: detrending of the relative cerebrovascular (rCBV) time course. Magn Reson Imaging 21 10 (2003) 1191-1200
37. Schwarz A.J., Danckaert A., Reese T., Gozzi A., Paxinos G., Watson C., et al. A stereotaxic MRI template set for the rat brain with tissue class distribution maps and co-registered anatomical atlas: application to pharmacological MRI. Neuroimage 32 2 (2006) 538-550
38. Schwarz A.J., Whitcher B., Gozzi A., Reese T., and Bifone A. Study-level wavelet cluster analysis and data-driven signal models in pharmacological MRI. J Neurosci Methods 159 2 (2007) 346-360
39. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates. 4th ed. (1998), Academic Press, San Diego
40. Smith S.M., Jenkinson M., Woolrich M.W., Beckmann C.F., Behrens T.E., Johansen-Berg H., et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23 Suppl 1 (2004) S208-S219
41. Friston K.J. Functional and effective connectivity in neuroimaging: a synthesis. Hum Brain Mapp 2 (1994) 56-78
42. Worsley K.J., Evans A.C., Marrett S., and Neelin P. A three-dimensional statistical analysis for CBF activation studies in human brain. J Cereb Blood Flow Metab 12 6 (1992) 900-918
43. Everitt B.J., and Robbins T.W. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci 8 11 (2005) 1481-1489
44. Kalivas P.W., and Volkow N.D. The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 162 8 (2005) 1403-1413
45. Nestler E.J. Is there a common molecular pathway for addiction?. Nat Neurosci 8 11 (2005) 1445-1449
46. Groenewegen H.J. Organization of the afferent connections of the mediodorsal thalamic nucleus in the rat, related to the mediodorsal-prefrontal topography. Neuroscience 24 2 (1988) 379-431
47. Uylings H.B., Groenewegen H.J., and Kolb B. Do rats have a prefrontal cortex?. Behav Brain Res 146 1-2 (2003) 3-17
48. Preuss T.M. Do rats have prefrontal cortex? The Rose-Woolsey-Akert program reconsidered. J Cogn Neurosci 7 1 (1995) 1-24
49. Vanderschuren L.J., and Everitt B.J. Drug seeking becomes compulsive after prolonged cocaine self-administration. Science 305 5686 (2004) 1017-1019
50. Martinez D., Gil R., Slifstein M., Hwang D.R., Huang Y., Perez A., et al. Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum. Biol Psychiatry 58 10 (2005) 779-786
51. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates. 5th ed. (2005), Amsterdam, Elsevier